| Drug Type Unknown | 
| Synonyms | 
| Target- | 
| Action- | 
| Mechanism- | 
| Therapeutic Areas | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePhase 1 | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 1 | Canada  | 06 Jan 2025 | |
| Metabolic dysfunction-associated steatotic liver disease | Phase 1 | Canada  | 06 Jan 2025 | 





